Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Translate Bio, Inc. (TBIO)
|
Add to portfolio |
|
|
|
| Price: |
$17.42
| | Metrics |
| OS: |
75.6
|
M
| |
|
|
| Market cap: |
$1.32
|
B
| |
|
|
|
Net cash:
|
$667
|
M
| |
$8.83
|
per share
|
|
EV:
|
$650
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($46.0)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 138.8 | 7.8 | 1.4 | 0.0 | 15.7 |
| Revenue growth | 1678.7% | 449.6% | | -100.0% | |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 26.8 |
| Gross profit | 138.8 | 7.8 | 1.4 | 0.0 | -11.1 |
| Gross margin | 100.0% | 100.0% | 100.0% | | -71.2% |
| Research and development | 109.6 | 76.4 | 58.0 | 47.0 | |
| General and administrative | 35.9 | 28.6 | 22.6 | 14.3 | 11.1 |
| EBIT | -55.3 | -97.2 | -104.2 | -79.2 | -26.8 |
| EBIT margin | -39.8% | -1245.6% | -7340.1% | | -171.2% |
| Pre-tax income | -53.8 | -113.8 | -103.0 | -78.9 | -26.7 |
| Income taxes | 0.0 | -0.5 | -5.6 | -12.5 | 0.0 |
| Tax rate | 0.0% | 0.4% | 5.4% | 15.8% | 0.0% |
| Net income | -53.8 | -113.3 | -98.0 | -67.2 | 0.0 |
| Net margin | -38.7% | -1451.7% | -6904.2% | | -0.2% |
| |
| Diluted EPS | ($0.80) | ($2.20) | ($3.64) | ($8.66) | ($18.14) |
| Shares outstanding (diluted) | 67.5 | 51.4 | 26.9 | 7.8 | 0.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|